• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Traws Pharma, Inc. - Common Stock (NQ:TRAW)

    2.250 +0.430 (+23.63%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 406,997
    Open 1.830
    Bid (Size) 2.160 (3)
    Ask (Size) 2.240 (107)
    Prev. Close 1.820
    Today's Range 1.830 - 2.250
    52wk Range 0.9700 - 19.44
    Shares Outstanding 5,564,315
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
    Via Investor Brand Network
    Annovis Appoints Mark Guerin as Chief Financial Officer
    From Annovis Bio Inc.
    Via GlobeNewswire

    Performance

    YTD
    -74.0%
    -74.0%
    1 Month
    +39.8%
    +39.8%
    3 Month
    +55.2%
    +55.2%
    6 Month
    +11.9%
    +11.9%
    1 Year
    -59.5%
    -59.5%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For August 14, 2025
    Via Benzinga
    Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
    From Traws Pharma, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Traws Pharma Posts Q2 Revenue Jump
    Via The Motley Fool
    Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
    From Traws Pharma, Inc.
    Via GlobeNewswire
    Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
    From Traws Pharma, Inc.
    Via GlobeNewswire
    Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
    Via Stocktwits
    Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
    From Traws Pharma, Inc.
    Via GlobeNewswire
    Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
    Via AB Newswire
    What's going on in today's session
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Which stocks are moving on Tuesday?
    Via Chartmill
    Dow Gains Over 100 Points; US Job Openings Increase In April
    Via Benzinga
    Topics Stocks
    Tuesday's session: gap up and gap down stocks
    Via Chartmill
    US Stocks Mixed; Dollar General Posts Upbeat Earnings
    Via Benzinga
    Tuesday's pre-market session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
    From Traws Pharma, Inc.
    Via GlobeNewswire
    Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
    From Traws Pharma, Inc.
    Via GlobeNewswire
    Traws Pharma Reports First Quarter 2025 Results and Business Highlights
    From Traws Pharma, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Traws Pharma, Inc. - Common Stock publicly traded?
    Yes, Traws Pharma, Inc. - Common Stock is publicly traded.
    What exchange does Traws Pharma, Inc. - Common Stock trade on?
    Traws Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Traws Pharma, Inc. - Common Stock?
    The ticker symbol for Traws Pharma, Inc. - Common Stock is TRAW on the Nasdaq Stock Market
    What is the current price of Traws Pharma, Inc. - Common Stock?
    The current price of Traws Pharma, Inc. - Common Stock is 2.250
    When was Traws Pharma, Inc. - Common Stock last traded?
    The last trade of Traws Pharma, Inc. - Common Stock was at 10/03/25 03:59 PM ET
    What is the market capitalization of Traws Pharma, Inc. - Common Stock?
    The market capitalization of Traws Pharma, Inc. - Common Stock is 12.52M
    How many shares of Traws Pharma, Inc. - Common Stock are outstanding?
    Traws Pharma, Inc. - Common Stock has 13M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.